Neovasc Inc. buy marge
Start price
16.10.18
/
50%
€563.75
Target price
16.04.19
€902.00
Performance (%)
-83.00%
End price
16.04.19
€95.84
Summary
This prediction ended on 16.04.19 with a price of €95.84. Massive losses of -83.00% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Neovasc Inc. | - | - | - | - |
iShares Core DAX® | 1.280% | 1.027% | 11.234% | 16.273% |
iShares Nasdaq 100 | -2.457% | -4.650% | 23.181% | 39.418% |
iShares Nikkei 225® | -2.006% | -2.091% | 6.745% | 6.545% |
iShares S&P 500 | -0.662% | -1.246% | 22.521% | 40.218% |
Comments by marge for this prediction
In the thread Neovasc Inc diskutieren
marge stimmt der Buy-Einschätzung von Thorsten_78 zu
10.10.2018 Neovasc announces that the FDA has granted Breakthrough Device designation to the Neovasc Reducer, a medical device for the treatment of refractory angina, which is not currently approved for commercial sale in the U.S.
(Laufzeit überschritten)